Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2024-12-23 00:00:00 ET · period of report 2024-12-20 · accession 0001415889-24-030084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-23 | 2024-12-20 | FENC | Raykov Rosty | Dir | M - OptEx | $2.69 | +25.0K | 91.4K | +38% | +$67.2K |
| D | 2024-12-23 | 2024-12-20 | FENC | Raykov Rosty | Dir | M - OptEx | $2.69 | -25.0K | 1.68M | -1% | -$67.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2024-12-20 | M | A | 25,000 | $2.69 | 91,432 | D | — | — | (F1) Shares acquired through the exercise of an option contract with strike price of $2.69 and an expiration date of December 31, 2024. |
| 2 | Derivative | Stock Options | 2024-12-20 | M | D | 25,000 | $2.69 | 1,675,000 | D | $2.69 · 2014-12-31 to 2024-12-31 | 25,000 options | (F1) Shares acquired through the exercise of an option contract with strike price of $2.69 and an expiration date of December 31, 2024. |